Register entry
Chongqing Huapont Pharmaceutical Co Ltd
Data as of · How to read this entry
- Registered sites
- 2
- Active NDC listings
- 10
- Labeller names
- 3
- Live patents
- 0
- Countries
- 1
- Base
- China
Authorisation
Registered operations
Active ingredient (API) manufacture2
Sites
Registered establishments
2| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Chongqing Huapont Shengchem Pharmaceutical Co., Ltd.Registrant: Chongqing Huapont Pharmaceutical Co Ltd | No 666 Rongjun Road, Nanjin Avenue, Hechuan District, Chongqing, 401520, China (CHN) | Active ingredient (API) manufacture | 3008481320421252563 |
| Chongqing Huapont Shengchem Pharmaceutical Co., Ltd.Registrant: Chongqing Huapont Pharmaceutical Co Ltd | No.6 Huanan 1st Road, Yanjia Avenue, Changzhou District., Chongqing, 401221, China (CHN) | Active ingredient (API) manufacture | 3030151600700322776 |
Catalogue
Drug listings by form and route
1010 active NDC listings: 10 bulk ingredient. By marketing category: BULK INGREDIENT 10.
| Dosage form | NDCs |
|---|---|
| powder | 10 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| chongqing huapont pharmaceutical co limited | 5 |
| chongqing huapont pharmaceutical co., ltd | 3 |
| chongqing huapont pharmaceutical co ltd | 2 |
Catalogue
Marketed products
10| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Acrivastine | powder | 48943-0035BULK INGREDIENT |
| - | Alitretinoin | powder | 48943-0012BULK INGREDIENT |
| - | Bendamustine Hydrochloride | powder | 48943-0019BULK INGREDIENT |
| - | Bexarotene | powder | 48943-0013BULK INGREDIENT |
| - | Isotretinoin | powder | 48943-0010BULK INGREDIENT |
| - | Micronized Bexarotene | powder | 48943-0014BULK INGREDIENT |
| - | Paricalcitol | powder | 48943-0033BULK INGREDIENT |
| - | Ruxolitinib phosphate | powder | 48943-0034BULK INGREDIENT |
| - | Tetrandrine | powder | 48943-0015BULK INGREDIENT |
| - | Tretinoin | powder | 48943-0011BULK INGREDIENT |
Neighbours
Registered in the same town
11- Chongqing Carelife Pharmaceutical Co., LtdChongqing, CHN · 2 sites
- CHONGQING SOUTHWEST NO. 2 PHARMACEUTICAL FACTORY CO., LTD.Chongqing, CHN
- Chongqing Alefa Technology Co., Ltd.ChongQing, CHN
- Chongqing Biocare Pharmaceutical Ltd.Chongqing, CHN
- Chongqing Bioland Pharmaceutical Ltd.Chongqing, CHN
- Chongqing Daxin Pharmaceutical Co., Ltd.Chongqing, CHN
- Chongqing Kangle Pharmaceutical Co., Ltd.Chongqing, CHN
- Chongqing Longjinsheng Medical Technology Co., Ltd.Chongqing, CHN
- Chongqing Sintaho Pharmaceutical Co., Ltd.Chongqing, CHN
- Porton Pharma Solutions LtdChongqing, CHN
- Yaopharma Co., Ltd.Chongqing, CHN
Compare
Comparable companies in China
- Shandong Xinhua Pharmaceutical Company Limited2 sites · 62 NDC
- Henan Lihua Pharmaceutical Co Ltd2 sites · 32 NDC
- Jiangsu Hansoh Pharmaceutical Group Co., Ltd.2 sites · 18 NDC
- Wisdom Pharmaceutical Co., Ltd.2 sites · 18 NDC
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd2 sites · 12 NDC
- Shandong Anxin Pharmaceutical Co., Ltd.2 sites · 11 NDC
- Hubei Biocause Heilen Pharmaceutical Co., Ltd2 sites · 10 NDC
- YiChang HEC ChangJiang Pharmaceutical Co., Ltd.2 sites · 8 NDC
- Chongqing Carelife Pharmaceutical Co., Ltd2 sites · 6 NDC
- Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd.2 sites · 6 NDC
Enquiry
Common questions
- Is Chongqing Huapont Pharmaceutical Co Ltd FDA approved?
- Chongqing Huapont Pharmaceutical Co Ltd holds 2 FDA-registered establishments in China. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Chongqing Huapont Pharmaceutical Co Ltd's drugs manufactured?
- The FDA register lists Chongqing. Registered operations: active ingredient (API) manufacture.
- What drugs does Chongqing Huapont Pharmaceutical Co Ltd make?
- 10 products are listed under Chongqing Huapont Pharmaceutical Co Ltd in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.